Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Broad Distribution of ZAP-70 Expression Is Demonstrated in Adult Acute Lymphoblastic Leukaemia by Quantitative PCR Analysis.

Geothy Kochethu, Andy Bell, Mike Griffiths, Gulnaz Begum, Farooq Wandroo, Paul A.H. Moss

Blood (2006) 108 (11): 4309.

https://doi.org/10.1182/blood.V108.11.4309.4309

Published: 2006

Journal Articles

Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol.

Sudhir Tauro, Gulnaz Begum, Grete Fossum Lauritzsen, Jan Delabie, Claudia Roberts, Premini Mahendra, Harald Holte

Blood (2006) 108 (11): 2438.

https://doi.org/10.1182/blood.V108.11.2438.2438

Published: 2006

Journal Articles

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

Mark Drayson, Gulnaz Begum, Supratik Basu, Sudhaker Makkuni, Janet Dunn, Nicola Barth, J. Anthony Child

Blood (2006) 108 (6): 2013–2019.

https://doi.org/10.1182/blood-2006-03-008953

Published: 2006

Journal Articles

Long-Term Survival in Patients Receiving Conventional Therapy for Newly Diagnosed Multiple Myeloma; Results from United Kingdom Medical Research Council Trials 1980–1997.

Bradley M. Augustson, MB;BS, Gulnaz Begum, BSc, Gareth J. Morgan, MD, J. Anthony Child, MD, Nicola J. Barth, Janet A. Dunn, PhD, Mark T. Drayson, PhD

Blood (2004) 104 (11): 4921.

https://doi.org/10.1182/blood.V104.11.4921.4921

Published: 2004

Journal Articles

Early Mortality Following Diagnosis of Multiple Myeloma; Analysis of Patients Entered into the UK Medical Research Council Trials 1980–2002.

Bradley M. Augustson, MBBS, Gulnaz Begum, BSc, Nicola J. Barth, Cert Clin Res, Janet A. Dunn, PhD, Gareth J. Morgan, MD, J. Anthony Child, MD, Mark T. Drayson, PhD

Blood (2004) 104 (11): 3465.

https://doi.org/10.1182/blood.V104.11.3465.3465

Published: 2004

Journal Articles

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4 + CD25 high regulatory T cells

Fiona J. Clark, Richard Gregg, Karen Piper, Debbie Dunnion, Lisa Freeman, Mike Griffiths, Gulnaz Begum, Premini Mahendra, Charles Craddock, Paul Moss, Ronjon Chakraverty

Blood (2004) 103 (6): 2410–2416.

https://doi.org/10.1182/blood-2003-06-2073

Published: 2004

NARROW

A Broad Distribution of ZAP-70 Expression Is Demonstrated in Adult Acute Lymphoblastic Leukaemia by Quantitative PCR Analysis.

Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol.

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

Long-Term Survival in Patients Receiving Conventional Therapy for Newly Diagnosed Multiple Myeloma; Results from United Kingdom Medical Research Council Trials 1980–1997.

Early Mortality Following Diagnosis of Multiple Myeloma; Analysis of Patients Entered into the UK Medical Research Council Trials 1980–2002.

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4 + CD25 high regulatory T cells

Email alerts

ASH Publications

American Society of Hematology

A Broad Distribution of ZAP-70 Expression Is Demonstrated in Adult Acute Lymphoblastic Leukaemia by Quantitative PCR Analysis.

Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol.

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

Long-Term Survival in Patients Receiving Conventional Therapy for Newly Diagnosed Multiple Myeloma; Results from United Kingdom Medical Research Council Trials 1980–1997.

Early Mortality Following Diagnosis of Multiple Myeloma; Analysis of Patients Entered into the UK Medical Research Council Trials 1980–2002.

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4 + CD25 high regulatory T cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only